Arnaud Foussat

Arnaud Foussat

Chief Executive Officer at
Yukin Therapeutics SAS
Health Technology
Consumer Services
Commercial Services

Profile

Arnaud Foussat was the founder of Alderaan Biotechnology SAS, founded in 2017, where the title held was Chief Executive Officer from 2017 to 2024.
The current job is Chairman at Yukin Therapeutics SAS, starting in 2019.
Former jobs include Principal at Institut National de la Santé & de la Recherche Médicale, and Chief Scientific Officer & Vice President at Sangamo Therapeutics France SAS from 2015 to 2017.
Education includes undergraduate studies at the University of Strasbourg and a doctorate from Université Paris Diderot-Paris 7.

Arnaud Foussat active positions

CompaniesPositionStart
Chief Executive Officer 01/06/2018

Former positions of Arnaud Foussat

CompaniesPositionEnd
Chief Executive Officer 01/03/2024
TXCELL Chief Tech/Sci/R&D Officer 01/03/2017
Corporate Officer/Principal -
See the detail of Arnaud Foussat's experience

Training of Arnaud Foussat

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

23

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Arnaud Foussat